Indian Pharmacopoeia Commission in the Interest of Drugs Safety

  • Farhan Ahmad Khan Professor, Department of Pharmacology, JNMC, AMU, Aligarh


Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Government of India. It is created to set the standards of drugs in the country. Its basic function is to regularly update the standards of drugs commonly used for the treatment of diseases. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP). It further promotes rational use of generic medicines by publishing National Formulary of India. IP prescribes standards for identity, purity and strength of drugs essentially required from health care perspective of human beings and animals. IPC also provides IP Reference Substances (IPRS) which act as a fingerprint for identification of an article under test and its purity as prescribed in IP. In addition, IPC is the National Coordinating Centre (NCC) for Pharmacovigilance Programme of India (PvPI), Materiovigilance Programme of India (MvPI), Haemovigilance Programme of India (HvPI) and Adverse Events Following Immunization (AEFI). On 30th October 2017, IPC has also become the WHO Collaborating Centre for Pharmacovigilance in Public Health Programmes and Regulatory Services.